FTSE and European Insurers - Economic Capital and Solvency II trends - money pit filled?

Interim Results season - without question, the most exciting time of the summer for me (although to qualify that, I do live on the Isle of Man and blog in my spare time). As good an opportunity as any to peer review where the big boys are at in the UK and Europe, both on Solvency II preparations/costs and economic captial positions.

Solvency II project costs - on the wane?

As I had mentioned in an earlier post, the FTSE-listed insurers have gone noticeably quiet on both Solvency II and, in the UK's case, the havoc it was inevitably going to wreak in its 2012 form - while the 2013 silence "speaks volumes" as to the priority of the dossier, it is a smart idea to see what impact the threat of a 2014 start has had to EC positions of major insurers over the last 12 months (i.e. after last year's whingeing, did any of them actually do substantive capital-related activity!)

A few notes for each below;

Aviva

• Solvency II project costs of £44m - well down on £77m in 2012 year-to-June
• "...there is still significant uncertainty over the detailed requirements [of Solvency II]"
• Pro-forma economic capital surplus of 175%, up from 172% in December
• IGD coverage 1.8 times, up from 1.7 times in December

Axa

• Nothing on Solvency II at all or project costs
• Solvency ratio down to 218% (from 233%) since December - interest rated attributed
• Economic solvency ratio (calibrated to 1-in-200 VaR) down to 204% (from 206%) since December - dividend and market risk elements attributed

Allianz

• Nothing on project costs
• Solvency ratio (based on FCD) of 177%, down from 197% this time last year - change in accounting standards attributed
• "...Allianz continues to be exposed to two external forces that adversely affect our risk profile and would not normally be associated with our core operating activities: the European sovereign debt crisis and regulatory developments – especially the European solvency directive, Solvency II"
• No reference to economic capital or modelling

Legal and General

• "Investment projects and expenses" (which covered Solvency II last year) were £20m - £23m in 2012 year-to-June
• "...remains uncertainty both to the implementation timescales of Solvency II and the final calibrations that will be used for long term business"
• IGD surplus unchanged at £4.1bn, coverage ratio down to 226%

Old Mutual

• No mention of Solvency II project costs, same as last year
• EC coverage of "over 160%", calibrated to VaR 99.93%
• FGD surplus of 160%
• Dividend outweighed operational cash flows in the 6 month period, though this was due to the special dividend paid last year after a massive disposal

Resolution

• Solvency II project costs of £10m for the half year - well down on the £48m for 2012 comparable!
• "Proposals for Solvency II continue to be the subject of debate"
• EC Coverage of 192% - (194% in Dec - quantum increased by £200m though)
• IGCA coverage of 221% (222% in Dec) - sold a business unit, which helped cover dividend

Prudential

• £13m Solvency II project costs for the half year - £27m in 2012 year-to-June
• "...deferral until 1 January 2016 or beyond appears likely"
• "...we now know that it will not be implemented before 1 January 2016" - my emphasis
• "[potential for] optimising the Group’s domicile as a possible response to an adverse outcome on Solvency II" remains on the table, a copy/paste threat left in from last year.
• IGD coverage of 230% - quantum lower by over a billion since Dec, due to a change in requirements in their US business

Standard Life

• £36m Solvency II "and other programmes" costs for the half year - £42m in 2012 year-to-June
• Solvency II project "...continues to respond to changes in requirements"
• IGD down £500m since half year after accounting for a special dividend, and surplus generation down year-on-year (attributed to new business strain)
• IGD surplus of 185%, down from over 200% at YE2012, but up 11% from this time last year
• Not a single reference to "economic capital" in the document

Generali

• No mention of Solvency II
• Solvency I coverage at 139% - up from 130% this time last year
• Economic capital coverage of 167% - up from 159% this time last year

RSA

• Solvency II project costs down to £10m (was £16m  in 2012 year-to-June)
• "There remains continued uncertainty as delays in agreeing the rules have caused the planned implementation date of 2014 to be delayed."
• IGD covered 1.7 times - down from 1.9 times since December - dividends again cited in explaining the dip.
• Economic capital (calibrated to 1-in-200 VaR) £1.3bn, up from £1.2bn in December.

So a trend of steady Solvency I ratios, and no sign of any war chests being created by holding excess cash back - quite the opposite in some cases, with dividends (special or otherwise) on the high side. With project costs diminishing and barely a passing comment on the Omnibus II impasse, it looks very much like Solvency II is yesterday's news in the boardrooms of major insurers. 

That said, in just those insurers covered above there has been over £100m confirmed spend in the last 6 months on Solvency II preparations, during which time the implementation date has (informally) moved at least two years, IMAP has been elongated, and the LTGA panacea has turned out to be anything but. That's hardly chickenfeed, and the rest of this year can only get busier for the UK with ICAS+ and EIOPA Interim Guidelines to contend with.

I hope Finance Directors don't get too excited by the dwindling project spend though - we haven't started Pillar 3 yet, apparently!

PwC and CSFI's 2013 Insurance Banana Skins survey - "Conduct Risk" firmly a la mode

Following on from the 2011 version, PwC and the Centre for the Study of Financial Innovation have pumped out another version of their Insurance Banana Skins survey, identifying how well the insurance industry feels it is prepared to handle a list of pre-identified risks. The average response on a scale of 1 to 5 was 2.97, which rather unrevealingly suggests the industry is averagely prepared to manage its collective risk profile.

EU Legislative process - not for vegans

This survey was conducted during March/April 2013, and elicited 662 responses from 54 countries, with two-thirds of respondents coming the insurance industry (the rest consultants/brokers etc). Almost half were European, so no surprises that the risks emerging from the regulatory environment were top of the pops for the second survey in a row. Solvency II gets a particularly flavoursome mention, with reference to its struggles to get through the "Brussels Sausage Machine"...

Bearing in mind the exquisite pressures being applied by the EU machinery to quantify risk, this publication is a welcome return to horizon scanning, qualitative assessment and emerging risk, all of which is handy for the ORSA posse, who according to recent surveys, should be all over this during 2013.

Some very interesting snippets emerge from the report, in particular;

• "Conduct Risk" - if ORSA was the new boy in 2012, then its 2013 counterpart is surely Conduct Risk, which I suspect didn't warrant a category of its own in many risk managers thinking until the return of twin peaks regulation in the UK. Conduct Risk has shot up the charts in its significance for insurers, now sitting 4th (from 18th last year)! Specifically, the suggestion that insurers are now "...looking beyond conduct risk as simply a compliance exercise" makes you wonder what some firms through were acceptable products in the last 10 years!
• "Guaranteed Products" - was not listed last time around, now jumps to number 6
• Actuarial Assumptions (which can easily mask the emergence of a number of the risks listed) unchanged at 12th
• Capital availability down from 2nd last time to 16th this year - interim period been spent squirrelling capital away, or happy that the onerous elements of Solvency II are (thanks to Germany) in the distant future?
• Reputational risk still in mid-table, at 14th

And sectoral/country specific;

• Surprisingly, the Life sector doesn't have actuarial assumptions in its top ten concerns
• Equally surprisingly, the non-life sector doesn't have regulation in its top ten concerns - clearly happy with their proposed Solvency II lot!
• That reputation doesn't feature in reinsurer's top ten - with customers likely to be eager yet more discerning  under Solvency II, one would think this is an area for enhancement in order to stand out from the similarly-rated crowd
• The quality of risk management appears to have spiked as a concern largely due to the emergence of emerging market firms into the space playing catch-up (on paper at least), as well as concerns that some firms are playing at risk management without making necessary adaptations to the prevailing risk culture.

Moody's survey on Solvency II compliance preparedness - the chilly third pillar

So from what I can gather it has been a terrible week for the Girondins, with a freak hailstorm wreaking havoc in a thin strip along the vineyards of Bordeaux's Entre-deux-Mers appellation - my in-laws were seemingly spared further down the river, noting that it was merely "un peux froid".

On Ice - Solvency II programmes
and this year's white Bordeaux?

And speaking of a great deal of hard work getting aimlessly destroyed by an unpredictable European storm, Solvency II (do you see what I did there?) appears to have at least enough juice in the tank to have encouraged Moodys to survey practitioners on the preparedness of the industry to achieve compliance before the deadlines currently on everyone's lips (i.e. 2014-2015 for EIOPA Guidelines, 2016 for "go-live").

That survey is available here (short sign-up required, but worth it), with a very short summary here. The media have touched on the survey (here), but only seem to have read the summary, so I've picked through the whole shooting match to see what else was worth knowing.

The sample is small at 45 contributors, but they have all been interviewed one-on-one in Q4 2012/Q1 2013, so the responses are not too dated, particularly as many Solvency II programmes have been running on meagre rations since January of this year. Coverage of 12 EU countries is included in the 45 people, with a decent split of size and insurance type. Majority of respondents were CRO/equivalent, with a few accountants, actuaries and programme managers thrown in for good measure, and just over half are on Standard Formula.

Talking points for me were;

• That 22% have frozen Pillar 3 activity, while 11% have frozen all Solvency II activity
• Half are using Standard Formula to curb costs!
• In addition to that, 20% say that the Use Test is a barrier to using models!
• 27% are approaching Pillar 1 and Pillar 3 with a tick-box mentality (i.e. happy to use multiple manual processes/excel-based tactical solutions to deliver the balance sheet and reporting template elements), while 44% have worked exclusively on Pillar 1 at the expense of Pillar 3
• Solvency II project investment levels are "considerably more" in the UK and France compared to Germany - makes you wonder why they have such a long face!
• 67% have increased their control function staffing by 10% or more - 31% have increased by 50% or more.
• Only 7% note "capital reduction" as a perceived benefit of Solvency II, with 33% selecting improved capital planning (regardless of quantum) as a benefit.
• Only 6.7% say they are receiving "high" levels of support from their national supervisory authority.

Seemingly the stats are a hostage to the sample - I'm sure the PRA would be apoplectic if this was the position of Insurers of Britain plc, but for me the big story is the indiscriminate swelling of Risk/control functions in smaller organisations that evidently are only ticking boxes. Feels a tad disingenuous to pump the staff numbers up to demonstrate compliance, but I suppose it's not me they need to satisfy!

Insurance Europe on EIOPA's place in the European System of Financial Supervision

As a response to the European Commission's consultation on the new European System of Financial Supervision (ESFS) - you know, the one that gave birth to EIOPA and the other two ESAs - Insurance Europe have laid some home truths down in this questionnaire document regarding the performance of EIOPA to date, as well as problems they see on the horizon once Omnibus II gets through.

Due to the lack of transparency in much of the work performed by EIOPA to date (a by-product of their remit being squirrelled away in the Omnibus II dossier?), I found some of this comment very revealing from a body which I expected would be relatively pally with them. Specifically, I noted the following opinions;

• That ESAs should not issue Guidelines that circumvent legislative powers - these generate blurred lines between technical matters (where their input is welcome) and strategic/political matters (where it is not). Precisely here that would leave EIOPA's Solvency II Interim Guidelines in their ideal world is another thing I guess, though they go on to say that the "...level of detail on the Solvency II implementing measures is alarming", and indeed were pretty vocal in their public response to them.

  

  EIOPA Guidelines - back door regulation?

• That there is an absence of clear definition in EIOPA's materials around where Regulatory Technical Standards (RTS), Implementing Technical Standards (ITS) and Guidelines differ - going on to suggest that there is an element of "regulation by the back door" in the Guidelines issued to date.
• Concern regarding the level of power left in EIOPA's gift to adopt RTS, citing as an example that EIOPA have brought back (as part of L3 consulations) a proposal to make external auditors review SFCRs - this proposal having already been jettisoned by the Parliament at L1!
• Suggest that the Commission should have a vote in contentious decisions within EIOPA (the Commission attend in a non-voting capacity currently) 
• A diva-esque rant (p12) about the quality of EIOPA's processes and outputs during consultations (lack of feedback, poor quality documentation), as well as suggesting that consultation participant quantums are overweight in academics at the expense of the industry.
• That some of the membership of Insurance Europe would welcome qualified majority voting in the ESAs weighted by size (let me guess who!).

So without having been handed their full schmorgasbord of powers, EIOPA are already being lambasted for their use of them - tough break!

Germany, BaFin and Solvency II - Tchüss wisely...

With the British Lions rugby team having had such a marvellous summer, it's nice to see that the spirit of "getting one's retaliation in first" has been brought back to Europe with them. The Executive Director of insurance at BaFin, the German regulator, came out swinging late last week (while the rest of Europe was lotioning up), and delivered his two'penneth worth on, amongst other matters, the Long Term Guarantees situation currently holding up Omnibus II.

Omnibus II trilogue - work to do

This is the same man who has recently been quoted as saying that delays are not a problem, as "Solvency II was not designed for today". Which is true - strictly speaking, it was designed for about 8 months ago!

The German contingent have been labelled in a number of articles (here, here, here and here) as a major source of legislative delay (presumably ever since they twigged that the proposed design of the extrapolation element was massively unfavourable to their industry), and the lobbying angles pursued here are not really new news, but to emphasise;

• Concerned about the increase in interest rates at Central Bank level - "should be carried out gradually", though rather disingenuously saying that they would have no influence in that - BaFin may not, but Chancellor Merkel and the overflowing pot of export surplus certainly does!
• Solvency II go-live of Jan 2016 "absolutely realistic" provided the trilogues are finished this year - I've noted in earlier posts that the official schedules of the co-legislators are looking shoddy in this respect, so I'm more inclined to side with S&P (and indeed the president of BaFin!)on 2016 being on shakier ground than a Hippo's decking..
• That transitional periods should be determined individually in accordance with a firms existing maturity profile - they want to avoid an insurer "falling over" just to meet the new regulation. Worrying that after 10 years of efforts, Solvency II compliance still carries such a credible threat of business closure! 
• As they have so many insurance contracts (90m cited), they would simply "say goodbye" in a worst-case scenario if they don't get their way on transitional periods.

So the likelihood of the German industry "taking one for the team" here is pretty small, and with Hrs Balz and Giegold having made it pretty clear that the LTGA result will not elicit a swift conclusion to trilogue negotiations, it looks like there's still plenty of talking to be done...

Deloitte's 8th Global Risk Management Survey - cause for concern?

A survey from Deloitte has recently hit the news stands, namely the 8th edition of their Global Risk Management Survey - I thought I'd postpone my August holidays to pick through the bones of it (?).

The data was gleaned from an online survey they sent out to CRO/equivalents back in Sept-Dec 2012, so is a bit dusty, and there were 86 respondents, so a half-decent sample. It isn't dominated by a particular sector or continent (p7), but there are more conglomerate/bank-heavy respondents than pure insurers.

There is an infographic for those of a short attention span with a few headline numbers, but having sifted through the larger doc, I found the following elements worthy of note;

Boards, Committees and Risk Management

• 80% of Boards are reviewing and approving Risk Management Policies/ERM Frameworks and Risk Appetite Statements. Bearing in mind the types of organisation in the sample, that is disappointingly low.
• 25% don't review individual risk policies
• 23% don't review strategy against risk profile
• Almost half don't invite CRO to EXCOM meetings
• Almost two-thirds delegate risk oversight to satellite committees (and two-thirds of those delegate to a Risk Committee)
• Only half have their Risk Committee chaired by an INED.
• Use of specific management risk committees for individual risk types tends to cluster around the 40-60% bracket (for example, 60% have an ERM committee, while 44% have an Op Risk Committee). Heavily weighted by organisation size i.e. larger ones tend to have them! 
• Emerging risk reporting not supplied to 30% of Boards
• Model validation results not supplied to 70% of Boards!
• 66% (of insurance respondents) have their Boards responsible for reviewing economic capital results

CRO and Risk Management Function

• 97% of large respondents have a CRO, 81% of smaller firms 
• 88% using "3 Lines of Defence" (almost all of the larger respondents do)
• 62% have an "ERM Programme"
• 58% increasing risk management budgets (still!)
• In the list of tasks currently performed by CROs, the fact that only 63% are involved in the approval of new business lines/products is pretty telling, and not in a good way.

Other control functions

• Almost half of respondents said that Internal Audit and the ERM Framework do not use common risk categories and language.
• 33% do not have a independent model validation 'function' (remember, the banks are in these stats as well!) - most of those who have made provision park it in the Risk Management function.

Risk management techniques

• 90% using some form of stress testing in the business, with most saying the outputs are used in business planning, strategy setting and identifying risk tolerance. More than half however don't use the outputs in the allocation of capital to lines of business.
• 74% have some type of Stress Testing policy
• Over 20% either do not have a Risk Appetite Statement, or only have a quantitative one
• Almost 70% still use regulatory capital as one of their quantitative measures in their Risk Appetite Statements
• Risk limits tending to be set at enterprise level, as opposed to business or desk/subsidiary level - stats are a little murky due to the emphasis towards banking sector.
• Model risk and Liquidity risk seem to be the risk types least factored in to companies ERM programmes

Management of Key Risks

• Full list on p24, with the percentage shown representing the number of respondents who thought their management of each risk was "extremely" or "very" effective - stand outs were that perceptions of the effectiveness of the management of Operational, Model, Outsourcing and Data risks appear to be much lower than one would hope, with Lapse risk management ranked unusually high.
• Op Risk KRIs and Loss data only collected in 60% of respondents
• Just over half are modelling Op Risk in some way - varying degrees of complexity experienced
• Most are using stress testing and/or reserving to assess Insurance risk - over 40% not currently using EC, and over 50% not using VaR.

Risk and Reward

• Almost 60% of remuneration schemes have no clawback provisions
• Almost 70% of schemes do not align incentive payouts with the term exposure of the underlying risks

Solvency II-specific

• 92% (of relevant responders) will focus resource on ORSA in next 12 months
• 77% will focus resource on Data Quality in next 12 months
• 69% will focus resource on Documentation and Reporting in next 12 months
• Less than 25% rate their processes and systems for Data Governance extremely/very effective.
• Declining trend of insurers who will be modelling economic capital (p19)
• Only 80% actually calculate Economic Capital
• Some very grim stats on p21 covering which risk types are modelled for EC purposes (underwriting risks seemingly very low on the list)

There are a number of areas touched on here which fall short of pending (or indeed actual) national/international regulations and codes, never mind "best practice". Perhaps we can account for the innate conservatism of CROs in their responses, and assume things aren't quite as bad as they have self-assessed here?

FTSE and European Interim Reporting - Solvency II off radar

So it's Interim Reporting time again for Europe's beleaguered insurers and as far as internal models go, another one has apparently bitten the dust - Old Mutual formally withdrew from the PRA's Internal Model Application Process in early 2013 "...as a result of delays in Solvency II implementation" (p14), joining Resolution on the sidelines.

Solvency II - 'Time of your life'?

This time around there appears to be a conspicuous absence of comment on Solvency II and indeed Omnibus II, unlike this time last year, when every firm had an opinion about Solvency II's legislative progress and its financial cost.

This is not so unusual for the mainland Europeans such as Allianz, Axa and Munich Re (all of whom had nothing new to say at the half year), but the UK firms have normally used the Interim Report as an opportunity to sound off. With Old Mutual (above) and  Legal and General so far only offering minor comments on "delays" and "uncertainty", have both the industry and the legislators given up forecasting the end game, and put the Solvency II "baby in the corner"?

Hopefully the remaining big hitters such as Pru, Aviva and Standard Life will have something to say over the next couple of weeks.

Central Bank of Ireland - Corporate Governance Code refresh

The Irish approach to corporate governance in financial services, at least up until the onset of the financial crisis in 2006/07, resembled something of an all-you-can-grasp buffet for a select number of executive golf club pals and octogenarian ex-politico Non-Executive Directors (NEDs), having their voting arms operated a la Weekend at Bernies.

Ireland pre-2007 - Waking NED?

The new FSA-flavoured approach brought in by Matthew Elderfield in 2009 (elaborated on here) fortified by the findings of a devastating 2011 report summarising the truly horrid governance practices in the Irish banking industry, has led to a change of regulatory tack at the Central Bank of Ireland that represents the biggest volte-face in Europe since the Macarena.

Alongside PRISM, a piece of revolutionary work in the assessment of financial institutions by supervisory bodies, the CBoI also made substantial changes in areas such as Annual Compliance Statements, Fitness and Probity of directors, Risk Appetite Statements.

All of this ran off the back of Mr Elderfield's first major gig in 2010, a full revamp of the Corporate Governance Code, which could hitch a ride off the back of the work of the FSA and CEIOPS (at the time!) and deliver a more substantial suite of obligations to a cabal of directors who, after feasting on carrots for years, desperately needed the stick.

This makes the release of yesterday's consultation on the Corporate Governance code a touch baffling, as the ink is barely dry on 2010's effort - it perhaps reflects that the regulator has reached optimum staffing levels if they can review it so regularly! Having said that, the level of divergence from accepted CG practices in the UK was flagged by Grant Thornton back in 2011 as being substantial, so a point-in-time revamp should not be so unwelcome, regardless of the proximity to the last one, and of course, all of this activity was too late to prevent Quinn Insurance from going down.

They emphasise that this review takes into account developments in the Solvency II space, as well as on-the-ground experience and publications from other parties of interest. Of particular note was their emphasis that, where national regulations are not as stringent as relevant EU or international one (or indeed vice versa?), the most onerous one should be complied with. In a number of instances around corporate governance, this will mean the CBoI outranking Solvency II as the more onerous of the two!

While these are proposals rather than stitched-on changes at this point, the CBoI doesn't have a great track record for backtracking these days. Highlights for me were;

Risk Committees

• Require a majority of NEDs on Risk Committees, and must be chaired by a NED

Committees in general

• Require the Risk Committee and Audit Committee chairs to sit on each other's committees
• Require the Remuneration Committee chair to sit on the Risk Committee
• In High Impact firms, the Risk Committee and Audit Committee Chair may not be the same person
• Must be at least 3 members of Risk Committees and Audit Committees

Chief Risk Officers

• They note that it is "Generally accepted best practice" to have a CRO who, amongst other tasks, is charged with "...facilitating risk appetite setting by the Board". In addition;
• All "High Impact" firms will be required to appoint a specialist CRO
• Firms with a lower PRISM rating may have a CRO who is shared with another control function, "...provided that there is no conflict of interest between the two roles". Can't help but feel that this might rule out CRO/Chief Actuary dual roles, but allows for CRO/Head of Compliance and CRO/Head of Internal Audit, which would be to the chagrin of the Society of Actuaries in Ireland!
• CRO to have direct access to the Chairman of the Board

Board Meeting frequency

• Seem to acknowledge that the compulsory 11 meetings per year for High Impact firms may be a touch much, so are looking for comments
• Also acknowledge that compulsory 1 meeting per calendar quarter is a bit constrictive for the smaller firms, so may relieve this to be pragmatic

Chairman and CEO

• Some of the restrictions around number of roles held at any one time to be relieved for smaller firms, but seemingly only to populate inter-Group roles.

Board Diversity

• Acknowledges that, while the debate in the EU is gender-centric, that diversity of all types is a worthy target for Boards, but falls short of compelling firms to do anything at national level, choosing to seek comments and wait for the supra-national activity to drive any compulsion. This seems to fit with the thinking of Irish directors published back in 2011 i.e. no "Golden Skirt" quotas.

Random

• "...appropriate Risk Culture" makes its way in (6.3), perhaps cognisant of the FSB's proposals
• Built in a piece which allows for video-conferencing rather than physical attendance at meetings (7.5)
• Board responsibilities updated (13.1)
• Compulsory Board skills matrix (14.9)

Solvency II, Omnibus II and Trilogue - two steps forward, two steps back?

Headline results from an Economist Intelligence Unit survey have been published this week, apparently suggesting that most global insurers continue to see Solvency II as their biggest regulatory challenge. Despite its prominence in the agendas of insurers' committees, boards and control functions, the legislation appeared to have taken a back seat in the decision-making fora of the European Union since the publication of EIOPA's LTGA in June.

So while the EU Parliamentarians go off for their hard earned 5 weeks in the sun (and by association Omnibus II/Solvency II will temporarily sit untouched like a pair of pink booties in Buckingham Palace), we can try and work out what the crack is with the dossier!

Trilogue
So with the Trilogue process itself necessarily one of closed doors, secret handshakes and unpublished shady deals, at least we formally know that they reconvened before the summer holidays thanks to Sharon Bowles' diary handler! Other than InsuranceERM's piece on a "muted start" to the negotiations (subscription only), the well is pretty dry on comment, suggesting that they got off to an inauspicious (re)start.

Parliament
As far as the latest ITER listings go (p1), ECON will not be considering the dossier again until 18th November 2013. From what I can read of the Parliamentary calendar, that is too close to supply the November Plenary with anything to vote on, and the December one is scheduled early in the month. Fair to say that, as indicated by Burkhard Balz last month, the Parliament won't vote on Omnibus II before 2014?

Council

Bed made - but covers stolen...

So the Lithuanian presidency is in town, and apparently sees the Omnibus II dossier as having "high importance" (p3) within their recently published work programme. ECOFIN have a state of play meeting provisionally scheduled for 15th October 2013.

That said, when pressed for comment when attending ECON before the summer holidays, they seems to have learned from the Paula Abdul school of making progress: for the two steps forward indicated by the Lithuanian Finance Minister's comment that the Presidency is committed to resolving, amongst other dossiers, Omnibus II (p12), he immediately takes two steps back by noting one of the key tactics will be "...focusing on uncontroversial technical issues to facilitate progress" (p13) - might be OK for some of the multitude of delayed dossiers, but not this one!

EIOPA
EIOPA naturally consider their work largely done for Omnibus II, and consider the report a "reliable basis" for making decisions on LTGs, and ultimately Omnibus II itself. Sr. Bernadino did however admit at the ABI conference a week back that, for 2016 to remain a viable "Go Live" date, political agreement on Omnibus II would be needed by the end of this year. Judging by Parliament's position above, I guess 2016 is out then!

European Commission
While Commissioner Barnier had lavished praise on EIOPA's, errr, "very good [LTGA] report", the Commission has lost its Solvency II specialist to retirement during this year, which might lead some observers to believe the Commission will be less effective as a negotiator while the new boy learns the ropes. However, Gideon managed to get some words from Karel van Hulle's replacement a couple of weeks back, and his modus operandi doesn't sound like one which will lead to a swift decision at the expense of one or two angry outliers in any case.

Specifically his comment that "We need to find a solution that works for almost all Member States. That is our ambition. So we don’t like to get the project through, just about ", suggests that anyone at the table with a gripe will get some airtime. With the LTGA outcome causing more gripe than at a constipated nursery, I suspect that the delays caused by the current 5 week vacance soleil will be a mere drop in the ocean...

PRA's take on EIOPA Guidance - no truck with dual reporting?

One of the Barnett Waddingham crew was kind enough to make a few notes about the PRA's current position, presented in an industry briefing back in early June (slides seemingly unavailable). While it didn't touch on pre-application for internal models, it did publicly tease out a few more details on ORSA and System of Governance from those already available, for example;

• The concept of a "Glide Path" towards ultimate Solvency II compliance, which is being agreed between firms and the PRA, to make up for the lack of certainty around both EIOPA's requirements from 2014 and of course the ultimate 'Go Live' date itself - gives both parties plenty of wriggle room in their preparations
• PRA are currently doing an "EIOPA vs PRA" comparison, but are not looking to change the PRA Handbook (which would neccesitate a consultation period, and therefore wouldn't be ready for 2014)
• That the PRA are not especially enamoured with their reporting requirements up to EIOPA!
• That the PRA believe that the trilogue discussions will be concluded before EIOPA's guidelines come into force. That seems less likely with every passing day
• That the PRA do not have the resources to feedback on any of the firms' efforts in the Solvency II reporting space

I guess the slightly odd thing is that the PRA have just announced a radically reduced Special Purpose Fee for Solvency II preparation (only £3.1m for IMAP, and a rebate for non-IMAP due to underspend last year - compare that to previous years!). Could they perhaps have just hung on to a bit more cash to provide a more substantial service in the next 18 months, or have they also given up the ghost on anything of substance happening in the foreseeable future?

ABI and PRA on 'Meeting the Challenges of a Changing World' - Solvency II in particular...

Low Yield issue - not just for insurers

While I disposed of my son for the summer last week for an extensive potty training course in Bordeaux (PS you might want to avoid the 2013 whites!), the ABI gathered the great and good for their biennial conference, themed Meeting the Challenges of a Changing World.

A corresponding publication from the ABI which the event hung its hat off to a certain extent is particularly useful for anyone in the emerging risk/ORSA/reverse stress testing space, touching on 7 specific 'challenge' themes, which are themself further broken into sub-categories. With the ABI providing a mouthpiece for the interests of the UK insurance industry (and being currently Chaired by an avid opponent of Solvency II), it was worth picking up on this document's take on Solvency II, specifically;

• That it could be a future constraint on the nascent equity release market
• Its well documented "...potential effects on infrastructure financing"
• That British insurers should "...[continue] being proactive and engaged in trying to shape vital regulation such as Solvency II rather than simply criticising it from the sidelines". Not sure if the implication is that the UK is drifting from the box-seat in this regard, but certainly in the context of the next decade, a slated in/out referendum on EU membership may make proactivity on Solvency II a moot point!

The regulatory meat in this lobbyist event sandwich came from a keynote speech by the PRA's Andrew Bailey which, in the process of publicly revealing a few nuggets of truth, still left me safe in the knowledge that insurance is still the banking industry's boring cousin - that he needed to "...make clear at outset that insurance supervision matters as much as banking supervision" and stress that "...insurance supervision is a skill on its own" while supporting most prevailing regulatory techniques with the prefix 'what we learned from Banking is...' tells its own story.

That aside, the following comments are worthy of highlighting;

• The PRA's current trend of using "business model analysis" in their supervisory work - surprised that this was not already par for the course frankly (what else other than the types of analyses referenced at the bottom of p4 would you be doing?), but one would expect that the advent of ORSA will enhance everyone's activity in this field soon.
• Taking that into account, it is "...logical for us to make early adjustments to our existing regime to incorporate the ORSA under ICAS+"
• The suggestion that management "...take responsibility for understanding and mitigating the risks in their business" - 'managing', rather than 'mitigating' surely, we'll tolerate anything within appetite!
• That the truly woeful "Solvency II/Crossrail" costing analogy used by Mr Bailey to a parliamentary select committee was the PRA "...making a point on behalf of firms".
• That "PRA have not withdrawn from involvement in Solvency II, far from it", though recognises that the result around the classic matching adjustment is not what UK plc would wish for - goes on to comment that we "...still have a good way to go to make the Solvency II regime manageable in its use and implementation"
• That, as far as Sol II's legislative progress is concerned, negotiations "...continue over summer, with a conclusion expected in the autumn", and that the official implementation date discussed recently on this blog is "clearly unrealistic".

In a week where a wall of silence has descended upon the co-legislators and the Commission, it is reassuring to see at least one NSA body with a solid-ish implementation plan, regardless of the immediate lack of things to implement - however judging by the words captured by Gideon of Dr. Wiedner, the lightly briefed (and from what I could read, lightly fed) replacement of Karel van Hulle, I suspect that Solvency II on the whole remains "Klaus but no cigar"...

Chartered Institute of Internal Auditors - final guidance on Effective Internal Audit for financial services

The Chartered Institute of Internal Auditors have followed up on their consultation earlier this year on Effective Internal Audit in the Financial Sector with this final set of recommendations.

Doesn't appear to have been any seismic changes as a result of the consultation, though the "need for proportionality" has been recognised, and clarification has been added that the content itself has not been mandated by the profession as best practice.

Interestingly, huge emphasis has been put on clarifying the primary role of Internal Audit as being the "protection" of a firms's assets, reputation and sustainability - does the profession feel well resourced and equipped to handle reputational defence? - while a few other elements sprung out at me;

• A focus remains on IA challenging the "tone at the top", as if the expression now carries so much weight and definition that professional guidance can be hung from it.
• "Risk Appetite" is again not defined, however IA are on the hook for assessing that it has been established and reviewed by senior management
• Emphatically declares that "...the assurance map cannot be carved up between the Risk, Compliance and Internal Audit functions", stressing that IA will be expected to include the challenge of the work of other control functions in their audit plans
• Built in some leeway around their earlier suggestion of compulsory attendance of IA function heads at Executive Committee meetings (ostensibly in order to understand strategy) - for insurers, one could anticipate that the advent of ORSA may take care of that knowledge gap 

Certainly the PRA/FCA have been fast to come out with support for the final version, so I guess all control functions had better make their peace with the content and prepare appropriately.

EU Commission and Quick Fix 2 - Silence is golden (delicious)...

We are a good week down the line since Solvency II technically became a rolling ball, at least from a 'transcription into national law' perspective, and the party has barely stopped around the EU...

Man from Del Monte
- he says 'Non-Compliant'

Joking aside, the wonderfully obscure lobbying miscreants at ICODA released findings (expanded on here) of a straw poll they had issued to all member states around their preparedness to implement both Solvency II and EIOPA's interim measures. Not even half of those polled responded, and only 6 responded in full, so the sample isn't ideal. That said, there are enough seeds of doubt sown by the responses to grow a Del Monte-style orchard of non-compliance by next year.

As one would have anticipated off the back of the last-ditch attempt to secure a second 'quick fix' Directive, there would appear to be major concerns around NSAs meeting the requirements as at 1st Jan 2014, for example;

• All respondees are in favour of 'Quick Fix 2'
• 40% don't feel adequately prepared for ORSA obligations
• Half are not prepared for internal model pre-application obligations
• A quarter are not prepared for submission of information obligations

Is 'Quick Fix 2' simply being seen by some of the straggling NSAs as an opportunity to postpone the inevitable rather than to actually prepare for it, thus avoiding the decadent yet ultimately unnecessary project spend of the early adopters? Indeed, is 'Quick Fix 2' even legally possible now that the date for transcription into national law has passed?

I took the opportunity on Monday 1st July to contact representatives of note to ask where the legislation currently stands, specifically around the potential for retrospective 'Quick FIx 2', and received the following cavalcade of replies in the last 7 days;

• EU Commission - nothing
• An EU Parliamentarian heavily involved in Solvency II - nothing
• EIOPA - a holding e-mail thanking me for my question

I hope that world exclusive information helps you all with your preparations!

Late post-script - I didn't bother checking in with the Council, but they have surprisingly made public comment today due to the changeover in presidencies to the Lithuanian delegation. Knowing the guys in Vilnius are big fans of the whole Solvency II shooting match (?), it was interesting to see they only have "...continued negotiations on the Omnibus II insurance dossier" scheduled over the next 6 months, as opposed to something more positive. We'll certainly be seeing Santa before the Parliamentary Plenary vote then, big question is will we also see the 2014 Easter Bunny?

Actuarial profession and the Risk Function - from 'land grab' to 'colonisation'?

Back in the early days of this Blog I used to post frequently on the Solvency II-sponsored creep towards Risk functions in insurers being 'Chiefed' by members of the actuarial profession as a matter of course rather than choice (here, here and here for a start). It was even a thread in a presentation I delivered to ILAG in late 2012 around areas of control function crossover, in particular that the actuarial profession was acknowledging that there were professional deficiencies in their ability to address the basics of an actuarial function under Solvency II, yet preferred the ambition of conquering a newer (less arduous?) space ahead of remedying them.

Whilst a quant is no doubt a decent fit for such a task, it was an evident snub to the nascent Risk Management 'profession', who took umbridge at the implication of such compulsion from the UK regulator in April 2011, though with seemingly little impact. However, limits to the amount of time and money bodies such as the IRM and FERMA can throw at developing a one-size-fits-all Risk Management qualification package that can appeal to quants and non-quants alike, plus some furious inter-squabbling in the ISO 31000 world, are certainly not lending any credence to "Risk Management" as a profession in its own right as we stand.

Risk and Actuarial professions - 'Poles' apart?

Over in Ireland, the opportunity for the Actuarial profession to secure an additional control function has been pursued so rabidly that the SAI incoming and outgoing presidents were recently able to congratulate themselves on having busted into "the new frontier" of Risk, and are now moving on into "colonisation mode" (p2)! In the UK, the Institute and Faculty of Actuaries already seem to consider that area of influence secured judging by the new president's remarks recently, indicating a desire to influence more mainstream debates than those around risk management systems and corporate governance.

The UK and Ireland don't appear to be the only ones afflicted by the perception of compulsory quants in Risk functions. Munich Re's excellent Knowledge Series delivers a Germanic take that there is "no doubt" that professional mathematicians will be needed for tomorrow's Risk functions.

When considering the history of the Actuarial profession (beautifully summarised here), there should be no reason why Risk Management cannot achieve a similar position given time, regardless of the disparity in existing approaches from representative bodies. A modular qualification which can prepare a 'risk professional' for their favoured activity (insurance buying/continuity management/financial risk/op risk/ERM) is surely an ambition which those bodies can harbour in concert? My concern would naturally be that I probably don't have another 50-100 years to wait for the that convergence to happen and enhance my own career prospects!

Or maybe I do - does anyone know an expert in longevity?

Solvency II delays - the unanswered questions...

There's a couple of unanswered questions loitering around in the Solvency II space which I'm sure a more plugged-in switched-on kind of girl could answer, but which I'm struggling to pin down. Looking forward to hearing from anyone on the following;

"Quick Fix 2" - as far as the paperwork from the first "quick fix" is concerned, the Solvency II 'clock' starts ticking on 30th June 2013, and despite the brave attempts of a cabal of Parliamentarians to obtain a second "quick fix", it seems like they failed. Is the clock really ticking for transposition into national law as of Monday?

Omnibus II - putting quick fixes to one side, the anticipation of EIOPA's LTGA report feeding into a positive EU Parliamentary Plenary vote in October 2013 was one of the anchors of what one might call a timely implementation calendar (i.e. 2016). In a typically unannounced manner, the indicative Plenary date, which had already been kicked down the road at least seven times, has this week been inauspiciously removed from the Procedure File entirely (confirmed here on the 'History' tab on 20/06/13).

With EU Parliamentary elections scheduled for May 2014, and Parliament begging for the Solvency II inertia to be broken beforehand, do we reasonably have another window to get Omnibus II through a Plenary vote before that political upheaval, or is the removal of an indicative date acceptance that the LTGA has generated more problems than it has solved?

(Level 2) Implementing measures - the European Commission had these timetabled in their 2013 "expected adoption dates" list, chalked down specifically for Q4 2013. In the last two months this has been removed from the list in its entirety (well spotted Norton Rose). Is this direct acknowledgement that, as indicated by Burkhard Balz last week, that there is no chance of Omnibus II clearing the Plenary hurdle this year?

Someone must know something - don't be shy!

EIOPA's Long Term Guarantees Assessment and the early fallout - Plenary delay pending?

EIOPA's Long Term Guarantees Assessment rocked up last week while I was enjoying my new arrival, perhaps the most eagerly anticipated document out of Frankfurt since the days of Goethe...

Wielded fiercely all year by all stakeholders in need of an excuse for the delays in Solvency II's legislative passage (and hence the need for more budget), it appears to have variously pleased everyone and no-one at the same time. The key findings/recommendations are nicely summarised here.

Major players have since piped up with the following over the last week, none of which suggests the report's conclusions will be ole'd through the trilogue and parliamentary vote. 

EU Institutions

EIOPA 

- "We are confident that the results of the LTGA, combined with the EIOPA advice will provide the EU political institutions with a reliable basis for an informed decision on the long-term guarantee measures and a conclusion on the Omnibus II negotiations"

EU Commission

- "The Commission trusts that the Council and Parliament will use this very good report and its findings as a basis for an urgent agreement on Omnibus II and show pragmatism and willingness to compromise"

EU Parliament (via Burkhard Balz)

- "Speaking for the European Parliament, we are very confident that Eiopa's work and the subsequent analysis will provide for a successful restart of the negotiations, and as rapporteur, I am ready to start as quickly as possible, even before the summer break, to pre-launch trilogue negotiations. It is our firm intention to conclude the long-term package before the end of this year, so we can adopt Omnibus II in early spring 2014"

Industry representative and lobbying bodies 

- Insurance Europe - "Insurance Europe’s preliminary review of EIOPA’s proposed improvements to the Solvency II regulatory regime shows that adaptations are needed to avoid unnecessarily damaging insurers’ ability to provide long-term guarantees and invest long-term"

- GCAE - "With the publication of the report, the EU is one step closer in the process to finalising the Solvency II dossier"

- UK's ABI - "The EIOPA report is a small step in the right direction. But there is still a long way to go before British pensioners can be confident of a reasonable deal on their annuities"

- Institute and Faculty of Actuaries - "Today’s proposals outlined by EIPOA (sic) would seem to address many of the important issues. However, the detail needs to be worked through and the effect in a variety of scenarios assessed, before the full implications of the proposals for companies and their customers can be understood"

Ratings agencies

- Fitch - EIOPA’s proposals “offer no prospect of an end to the long-running dispute between regulators and insurers over suitable capital levels for products with long-term investment guarantees"

Print Media

- Commercial Risk Europe - "...unlikely to resolve key issues stalling the implementation of Solvency II and may lead to yet further delays to the Directive"

Consultancies

- PWC - "many insurers may find the proposals onerous and will not welcome the continued uncertainty over the final rules. We anticipate there may be concerns about the capital required for certain types of assets backing annuities in particular; and the effectiveness of measures designed to address short-term asset volatility"

- KPMG - "...it is likely that certain European countries will look very unfavourably at the EIOPA proposals."

I have emboldened the quote from Burkhard Balz above which suggests that the Omnibus II vote is going to move again. The rationale for that is two-fold; the prospective Plenary date (which was down as October 2013) appears to have suspiciously disappeared from the EU Parliament's Omnibus II procedure file altogether, while Mr. Balz clearly states early 2014 is targeted 'adoption date' while 'speaking on behalf of the Parliament'!

Institute of Risk Management's latest on ORSA - presentations and surveys

I haven't kept too much of an eye on the IRM's Solvency II Special Interest Group activity, which during 2011/12 was prolific, but with the disappearance of the finishing line, I suspected there may have been some fall off. There has certainly been a Partidge-esque rebadging of it (now called 'ERM in Insurance'), which I suspect helps most attendees justify to their bosses, in the face of interminable Solvency II delays, taking half a day off to attend these shindigs!

Rebadged - IRM's Solvency II SIG

A recent one on the incorporation of ORSA into the business planning process is worth highlighting, being focused (at least on the face of it) on the more visceral elements of the ORSA process rather than the theory. While the Kiln CRO seemingly had more to say than was put on his slides, the Allianz UK Head of Op Risk noted a few things which those working in the field would benefit from benchmarking against;

• Risk department seemingly responsible for ORSA report production
• 'Record of ORSA Process' documentation - shooting for around 60 pages, which feels light to me as a "record" (about par for a "report" perhaps?)
• ORSA Board report - summarised from the 60 pages referenced above, so again light
• Lists some 'example' ORSA triggers, which are good for peer comparison
• Seemingly will be validating their ORSA process, despite it not being a regulatory requirement.

The IRM's related survey also produced some notable material, particularly around participation levels - only 14 participants, compared to 22 back in 2011 and 33 this time last year, showing perhaps the extent of the fatigue on the matter. With the tiny sample also heavy in GI firms, one might take any revelations with a pinch of salt, however, I spotted;

• Frequency - A quarter are planning to run the ORSA process quarterly, most going annually
• Preparedness - Areas such as data quality, ORSA validation, ORSA record keeping and the forward-looking assessment are all lagging
• Projection length - 80% going for 3 years, though the GI heaviness of the sample will have skewed this for sure
• Projection technique - around half doing future years in isolation, and half doing multi-year (dependent) projections
• Forward looking assessment - All respondents are factoring in expected risk profile changes into their FLAs
• Stress & Scenario Testing - All respondents using scenarios with interdependencies, while two are not using reverse stress testing at all.

More from EIOPA and PRA on internal models - anything you can do...

Certainly looks like there is a bit more mileage in this back-and-forth around internal models and the assessing of their appropriateness. As I posted recently, the UK's PRA have come out fighting on the subject of 'Early Warning Indicators' (EWIs) to highlight where a company's internal model, for fair reasons or foul, may be measuring the Solvency Capital Requirement in a way which does not meet the required calibration standard of the 1-year VaR at 99.5th percentile.

Early Warnings - time well spent?

EIOPA, through the words of their Chairman, have already made a pitch for assessing internal models on behalf of our overworked national supervisors, at least at some point in the medium-term future. It would now appear they have also piggy-backed the PRA's work around developing and monitoring EWIs as well!

That article is on Risk.net, so for non-subscribers, EIOPAs work is specifically looking at (in the author's words, not EIOPA's) "...threats to a firms solvency that are not picked up by the company's internal model". These will include qualitative and quantitative measures, and are due to be discussed (by their internal models committee) in the Autumn -  you know, that relatively quiet point in the Solvency II implementation calendar...

The EWI article was published at the same time as an interview with Sr. Bernadino and Insurance Risk magazine was released, where the tone of the interview is particularly aggressive around EIOPA's inability to compel national supervisors to "comply" with their recently-issued preparatory guidance. Whilst it is hard not to admire his optimism ("we are moving closer to the date of implementation"), he is quite fixated with "some countries" who, without EIOPA's guiding hand, he feels would end up divergent from the rest of the market.

I certainly am not familiar enough with continental Europe's positions as it stands, but it certainly reads like a not-too-subtle finger point at Royaume-Uni at the very least. He also goes on to mention that, while 'full Board support' was received at EIOPA to issue the preparatory guidance, not all participants were 'completely happy'. One would certainly feel aggrieved at the smaller end of insurance supervisors to comply-or-explain on preparations for a new regime which doesn't have a kick-off date, while still having to administrate the existing one!

An interesting side-issue around potential discord amongst the states is this recent request (which I have procured through the magic of Google!) from most of the Member States for a second "quick-fix" Directive, based on the fact that some of the implementation countdown dates that feature in the first one are next month (good spot Gideon)! According to the letter, the Commission already appear to have singularly ruled out the need for another quick-fix,

Four countries didn't make it onto the list of senders (Ireland, Netherlands, Malta and Lithuania) - not concerned, or not consulted?

Also worth highlighting the recent spectacularly ill-timed London press strafing of the internal modelling world - an strange development, particularly at the same time that the UK Independence Party has been lifting up its dress for London's financial sector to have a gander underneath. With some of the UK's bigger beasts such as L&G and Pru already openly hostile to Solvency II (and Resolution being an early faller in the IMAP stakes), is there potential for the rinsed-out UK insurance sector to throw its weight behind a political force such as UKIP, who would happily make an EU Directive bonfire, using Solvency II for kindling?

EIOPA and PRA - model appropriateness, expanding remits and early warnings

Another short flurry of activity recently on the Solvency II front ahead of the day (well, 'month') of reckoning for the Long Term Guarantees assessment. The industry media is certainly very chipper around the prospects of a deal being done off the back of the LTGA (here and here), highlighting that some German products may be the beneficiaries of this new found camaraderie (here).

German products - carved out from 

LTG requirements?

EIOPA themselves have been vocal on power extension this week, with Sr Bernadino making a few waves in his submission to a public hearing on Financial Supervision in the EU. Apart from his Partridge-esque diatribe about 'evolution, not revolution', he also highlighted what he considers enhancements to the existing supervisory structure in the EU, namely:

1. Strengthening EIOPA's operational independence - effectively through a change in its funding arrangements, going as far a potentially levying the industry direct, and also by having more money in any case (referred to cheekily as 'budgetary flexibility'!).
2. Reinforcing its existing 'independent challenge' role - by securing access to national supervisors' QRT data and allowing EIOPA to conduct EU-wide investigations of conduct-related issues (effectively an FCA for Europe!)
3. Enhancing both its mandate and powers - perhaps most controversially, fishing for centralised oversight of internal models, as well as powers to ban or restrict activities in member states.

One might say to EIOPA 'don't walk before you can toddle', but I guess if we are serious about operating a single market, the UK's consumers shouldn't need to rely on generally being in the vanguard on these matters (both producing nefarious financial products, then banning them and recouping the profits for compensation!)

Back to the UK's national regulator, the PRA dropped a few pearls of administrative agony for the insurance industry this week, with a couple of 'dear CEO' letters which were part-briefing and part-data request, ultimately driven by the UK's aggressive take on assessing internal model adequacy (i.e the same activity which EIOPA wishes to expropriate from national hands!). 

The purpose of the letters is nicely summarised by Chris Finney here, so I only need to highlight a couple of elements for my own interest;

Solvency II update letter

• "Unlikely to be any certainty" on timetable before autumn
• "Just under half" of IMAP candidates have applied to participate in ICAS+
• They are hoping to share learnings from ICAS+, "particularly developments used by firms in their modelling techniques" - danger here of the early birds determining what's hot and what's not in the world of assumptions/calibration/expert judgement/documentation for those not participating in ICAS+?
• Highlight pension risk as one area where the standard formula is potentially not suitable
• Next industry briefing forecast for late November (post-Omnibus II ratification?) - that's what I call 'scaling back' on costs!

Early Warning Indicators letter - remember here that the PRA's plans are potentially at odds with EIOPA's, to the extent that the PRA are already braced for some kind of legal challenge

• EWI's aim to test calibrations of internal models as well as "monitor any downward drift in capital" - presumably just quantity for the latter?
• Ratios being monitored are of pre-corridor MCRs (as illustrated in firm's LTGA submissions earlier this year) against current Individual Capital Guidance - once we go live, this is likely to be replaced by modelled SCR
• Special treatment for With-profits business to account for the fineries of that sector (cost of guarantees, level of free assets and the proportion of non-profits written in the book)
• Ratios are deliberately set so that 10% of affected firms will fall below
• Information required to conduct this work is covered by the data collection exercise below

Data collection exercise letter

• Fishing for data from all internal model applicants using YE2012 balance sheets (unless you can excuse using earlier data) which covers standard formula SCR, Internal Model SCR and ICAS by end of July.
• Also asking Life firms for key percentiles from distributions for 'risk variables' - one assumes this means each one of the risk drivers in one's SCR calculation.
• Conducting what seems to be peer review work around credit stresses and stochastic simulation files (for anyone using them).

With EIOPA and the PRA both seemingly interested in being top dog in the world of assessing model appropriateness, it looks like we might need a walk-off...

Judging model appropriateness - EIOPA or PRA?